Myelin-based inhibitors of oligodendrocyte myelination: Clues from axonal growth and regeneration

Neuroscience Bulletin

Volumn 29, Issue 2, 2013, Pages 177-188

  Mei, Feng ^a   Christin Chong, S Y ^a   Chan, Jonah R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

differentiation; ephrin; LINGO 1; myelin; netrin 1; nogo A; semaphorin

Indexed keywords

EPHRIN; LINGO 1 PROTEIN; MYELIN; MYELIN BASED INHIBITOR; MYELIN BASIC PROTEIN; NETRIN 1; PROTEIN INHIBITOR; PROTEIN NOGO A; SEMAPHORIN; UNCLASSIFIED DRUG;

ANTERIOR COMMISSURE; BRAIN CORTEX; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CORPUS CALLOSUM; CORPUS STRIATUM; EXTERNAL CAPSULE; HUMAN; INSULA; MICROENVIRONMENT; MYELINATION; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; REGULATORY MECHANISM; REMYELINIZATION; REVIEW; SOMATOSENSORY CORTEX; TRANSGENIC MOUSE;

ANIMALS; AXONS; BRAIN; HUMANS; MEMBRANE PROTEINS; MYELIN PROTEINS; MYELIN SHEATH; NERVE GROWTH FACTORS; NERVE REGENERATION; OLIGODENDROGLIA; TUMOR SUPPRESSOR PROTEINS;

EID: 84877853300     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-013-1319-x     Document Type: Review

References (114)

1. Nave KA. Myelination and support of axonal integrity by glia. Nature 2010, 468: 244-252.
2. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012, 487: 443-448.
3. Miller RH. Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 2002, 67: 451-467.
4. Richardson WD, Kessaris N, Pringle N. Oligodendrocyte wars. Nat Rev Neurosci 2006, 7: 11-18.
5. Franklin RJM, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008, 9: 839-855.
6. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000, 20: 6404-6412.
7. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002, 125: 338-349.
8. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 2000, 123: 105-115.
9. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129: 3165-3172.
10. Kuhlmann T, Miron V, Cui Q, Cuo Q, Wegner C, Antel J, et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008, 131: 1749-1758.
11. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, et al. Common developmental requirement for Olig Function indicates a Motor Neuron / Oligodendrocyte Connection. Cell 2002, 109: 75-86.
12. Zhou Q, Wang S, Anderson DJ. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000, 25: 331-343.
13. Lu QR, Yuk D, Alberta J, Zhu Z, Pawlitzky I, Chan J, et al. Sonic hedgehog - regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 2000, 25: 317-329.
14. Zhou Q, Choi G, Anderson DJ. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 2001, 31: 791-807.
15. Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 2002, 109: 61-73.
16. Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol 2002, 12: 1157-1163.
17. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 2009, 23: 1571-1585.
18. Li H, He Y, Richardson WD, Casaccia P. Two-tier transcriptional control of oligodendrocyte differentiation. Curr Opin Neurol 2009, 19: 479-485.
19. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002, 346: 165-173.
20. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 2008, 11: 1392-1401.
21. Horner PJ, Power a E, Kempermann G, Kuhn HG, Palmer TD, Winkler J, et al. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 2000, 20: 2218-2228.
22. Gensert JM, Goldman JE. Demyelinated Axons in the Adult CNS. Neuron 1997, 19: 197-203.
23. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman R A, McKhann G, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004, 10: 93-97.
24. Chong SYC, Chan JR: Tapping into the glial reservoir: cells committed to remaining uncommitted. J Cell Biol 2010, 188: 305-12.
25. Chong SYC, Rosenberg SS, Fancy SPJ, Zhao C, Shen YA, Hahn AT, et al. Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination. Proc Natl Acad Sci U S A 2012, 109: 1299-1304.
26. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 2006, 9: 173-179.
27. Dawson M. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 2003, 24: 476-488.
28. Kirby BB, Takada N, Latimer AJ, Shin J, Carney TJ, Kelsh RN, et al. In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nat Neurosci 2006, 9: 1506-1511.
29. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao X, Bu H, et al. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 2009, 12: 829-838.
30. Shen S, Sandoval J, Swiss V, Li J, Dupree J, Franklin RJM, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 2008, 11: 1024-1034.
31. Popko B. Epigenetic control of myelin repair. Nat Neurosci 2008, 11: 987-988.
32. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 2002, 22: 10333-10345.
33. Shen S, Li J, Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 2005, 169: 577-589.
34. Ruckh JM, Zhao JW, Shadrach JL, Van Wijngaarden P, Rao TN, Wagers AJ, et al. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 2012, 10: 96-103.
35. Redmond S, Chan JR. Neuroscience. Revitalizing remyelination - the answer is circulating. Science 2012, 336: 161-162.
36. Lee S, Leach MK, Redmond SA, Chong SYC, Mellon SH, Tuck SJ, et al. A culture system to study oligodendrocyte myelination processes using engineered nanofibers. Nat Methods 2012, 9: 917-922.
37. Voyvodic JT. Target size regulates calibre and myelination of sympathetic axons. Nature 1989, 342: 430-433.
38. Lee X, Yang Z, Shao Z, Rosenberg SS, Levesque M, Pepinsky RB, et al. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci 2007, 27: 220-225.
39. Jepson S, Vought B, Gross CH, Gan L, Austen D, Frantz JD, et al. LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions. J Cell Biol 2012, 287: 22184-22195.
40. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, et al. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci U S A 2000, 97: 7585-7590.
41. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 2002, 125: 1972-1979.
42. Barres B, Raff MC. Axonal control of oligodendrocyte development. J Cell Biol 1999, 147: 1123-1128.
43. Clarke LE, Young KM, Hamilton NB, Li H, Richardson WD, Attwell D. Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex, and piriform cortex of the mouse. J Neurosci 2012, 32: 8173-8185.
44. Cammermeyer J. The distribution of oligodendrocytes in cerebral gray and white matter of several mammals. Am J Anat 1960, 107: 107-127.
45. Hahn AT, Chan JR. A collaboration conducive to conduction: matching axonal density to oligodendroglial number (Commentary on Kawai et al.). Eur J Neurosci 2009, 30: 2029.
46. Kawai K, Itoh T, Itoh A, Horiuchi M, Wakayama K, Bannerman P, et al. Maintenance of the relative proportion of oligodendrocytes to axons even in the absence of BAX and BAK. Eur J Neurosci 2009, 30: 2030-2041.
47. Rosenberg SS, Kelland EE, Tokar E, De la Torre AR, Chan JR. The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation. Proc Natl Acad Sci U S A 2008, 105: 14662-14667.
48. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, et al. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 2009, 132: 465-481.
49. Kotter MR, Li WW, Zhao C, Franklin RJM. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 2006, 26: 328-332.
50. Domeniconi M, Zampieri N, Spencer T, Hilaire M, Mellado W, Chao M V, et al. MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 2005, 46: 849-855.
51. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002, 417: 941-944.
52. Kottis V, Thibault P, Mikol D, Xiao ZC, Zhang R, Dergham P, et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 2002, 82: 1566-1569.
53. Caroni P, Schwab ME. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 1988, 106: 1281-1288.
54. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003, 4: 703-713.
55. Schwab ME. Nogo and axon regeneration. Curr Opin Neurol 2004, 14: 118-124.
56. Dickson BJ. Molecular mechanisms of axon guidance. Science 2002, 298: 1959-1964.
57. Yu TW, Bargmann CI. Dynamic regulation of axon guidance. Nat Neurosci 2001, 4Suppl: 1169-1176.
58. Giger RJ, Hollis ER, Tuszynski MH. Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol 2010, 2: a001867.
59. Fox M, Afshari F, Alexander J, Colello R, Fuss B. Growth conelike sensorimotor structures are characteristic features of postmigratory, premyelinating oligodendrocytes. Glia 2005, 566: 563-566.
60. Jarjour A, Kennedy TE. Oligodendrocyte precursors on the move: mechanisms directing migration. Neuroscientist 2004, 10: 99-105.
61. Sloane J, Vartanian TK. Myosin Va controls oligodendrocyte morphogenesis and myelination. J Neurosci 2007, 27: 11366-11375.
62. Huber AB, Weinmann O, Brösamle C, Oertle T, Schwab ME. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002, 22: 3553-3567.
63. Chen MS, Huber B, Van der Haar ME, Frank M, Schnell L, Spillmann A, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403: 434-439.
64. Hu F, Strittmatter SM. The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrinspecific mechanism. J Neurosci 2008, 28: 1262-1269.
65. Mimura F, Yamagishi S, Arimura N, Fujitani M, Kubo T, Kaibuchi K, et al. Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism. J Cell Biol 2006, 281: 15970-15979.
66. Fournier AE, Takizawa BT, Strittmatter SM. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 2003, 23: 1416-1423.
67. Fournier AE, Grandpre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001, 409: 341-346.
68. Mi YJ, Hou B, Liao QM, Ma Y, Luo Q, Dai YK, et al. Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity. Cell Differ Dev 2012, 19: 1175-1186.
69. Wong ST, Henley JR, Kanning KC, Huang K, Bothwell M, Poo M. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 2002, 5: 1302-1308.
70. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005, 45: 353-359.
71. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004, 7: 221-228.
72. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He XL, et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005, 45: 345-351.
73. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005, 8: 745-751.
74. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nature Med 2007, 13: 1228-1233.
75. Mi S, Sandrock A, Miller RH. LINGO-1 and its role in CNS repair. Int J Biochem Cell B 2008, 40: 1971-1978.
76. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009, 65: 304-315.
77. Zhao XH, Jin WL, Ju G. An in vitro study on the involvement of LINGO-1 and Rho GTPases in Nogo-A regulated differentiation of oligodendrocyte precursor cells. Mol Cell Neurosci 2007, 36: 260-269.
78. Ji B, Li M, Wu WT, Yick LW, Lee X, Shao Z, et al. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol Cell Neurosci 2006, 33: 311-320.
79. Jalink K, Van Corven EJ, Hengeveld T, Morii N, Narumiya S, Moolenaar WH. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J Cell Biol 1994, 126: 801-810.
80. Liang X, Draghi N, Resh MD. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 2004, 24: 7140-7149.
81. Nikolic M. The role of Rho GTPases and associated kinases in regulating neurite outgrowth. Int J Biochem Cell B 2002, 34: 731-745.
82. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Bio 2005, 6: 789-800.
83. Dewit J, Verhaagen J. Role of semaphorins in the adult nervous system. Prog Neurobiol 2003, 71: 249-267.
84. Huber AB, Kolodkin AL, Ginty DD, Cloutier JF. Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance. Ann Rev Neurosci 2003, 26: 509-563.
85. Koeberle PD, Bähr M. Growth and guidance cues for regenerating axons: where have they gone? J Neurobiol 2004, 59: 162-180.
86. Giraudon P, Vincent P, Vuaillat C, Verlaeten O, Cartier L, Marie-Cardine A, et al. Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells. J immunol 2004, 172: 1246-1255.
87. Moreau-Fauvarque C, Kumanogoh A, Camand E, Jaillard C, Barbin G, Boquet I, et al. The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci 2003, 23: 9229-9239.
88. Yamaguchi W, Tamai R, Kageura M, Furuyama T, Inagaki S. Sema4D as an inhibitory regulator in oligodendrocyte development. Mol Cell Neurosci 2012, 49: 290-299.
89. Bernard F, Moreau-Fauvarque C, Heitz-Marchaland C, Zagar Y, Dumas L, Fouquet S, et al. Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination. Glia 2012, 60: 1590-1604.
90. Goldberg JL, Vargas ME, Wang JT, Mandemakers W, Oster SF, Sretavan DW, et al. An oligodendrocyte lineage-specific semaphorin, Sema5A, inhibits axon growth by retinal ganglion cells. J Neurosci 2004, 24: 4989-4999.
91. Leslie JR, Imai F, Fukuhara K, Takegahara N, Rizvi T, Friedel RH, et al. Ectopic myelinating oligodendrocytes in the dorsal spinal cord as a consequence of altered semaphorin 6D signaling inhibit synapse formation. Development 2011, 138: 4085-4095.
92. Prestoz L, Chatzopoulou E, Lemkine G, Spassky N, Lebras B, Kagawa T, et al. Control of axonophilic migration of oligodendrocyte precursor cells by Eph-ephrin interaction. Neuron Glia Biol 2004, 1: 73-83.
93. Worzfeld T, Rauch P, Karram K, Trotter J, Kuner R, Offermanns S. Mice lacking Plexin-B3 display normal CNS morphology and behaviour. Mol Cell Neurosci 2009, 42: 372-381.
94. Benson MD, Romero MI, Lush ME, Lu QR, Henkemeyer M, Parada LF. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci U S A 2005, 102: 10694-10699.
95. Round J, Stein E. Netrin signaling leading to directed growth cone steering. Curr Opin Neurol 2007, 17: 15-21.
96. Killeen MT, Sybingco SS. Netrin, Slit and Wnt receptors allow axons to choose the axis of migration. Dev Biol 2008, 323: 143-151.
97. Löw K, Culbertson M, Bradke F, Tessier-Lavigne M, Tuszynski MH. Netrin-1 is a novel myelin-associated inhibitor to axon growth. J Neurosci 2008, 28: 1099-1108.
98. Jarjour A, Bull SJ, Almasieh M, Rajasekharan S, Baker KA, Mui J, et al. Maintenance of axo-oligodendroglial paranodal junctions requires DCC and netrin-1. J Neurosci 2008, 28: 11003-11014.
99. Tsai HH, Macklin WB, Miller RH. Netrin-1 is required for the normal development of spinal cord oligodendrocytes. J Neurosci 2006, 26: 1913-1922.
100. Rajasekharan S, Baker KA, Horn KE, Jarjour A, Antel JP, Kennedy TE. Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development 2009, 136: 415-426.
101. Tsai HH. Netrin 1 mediates spinal cord oligodendrocyte precursor dispersal. Development 2003, 130: 2095-2105.
102. Rajasekharan S, Bin JM, Antel JP, Kennedy TE. A central role for RhoA during oligodendroglial maturation in the switch from netrin-1-mediated chemorepulsion to process elaboration. J Neurochem 2010, 113: 1589-1597.
103. Manitt C, Colicos M, Thompson KM, Rousselle E, Peterson C, Kennedy TE. Widespread expression of netrin-1 by neurons and oligodendrocytes in the adult mammalian spinal cord. J Neurosci 2001, 21: 3911-3922.
104. Serafini T, Colamarino S, Leonardo ED, Wang H, Beddington R, Skarnes WC, et al. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell 1996, 87: 1001-1014.
105. Deiner MS, Sretavan DW. Altered midline axon pathways and ectopic neurons in the developing hypothalamus of netrin-1- and DCC-deficient mice. J Neurosci 1999, 19: 9900-9912.
106. Sherman DL, Brophy PJ. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 2005, 6: 683-690.
107. Dou CL, Levine JM. Identification of a neuronal cell surface receptor for a growth inhibitory chondroitin sulfate proteoglycan (NG2). J Neurochem 1997, 68: 1021-1030.
108. Llorens F, Gil V, Del Río JA. Emerging functions of myelinassociated proteins during development, neuronal plasticity, and neurodegeneration. FASEB 2011, 25: 463-475.
109. Wang H, Tewari A, Einheber S, Salzer JL, Melendez-Vasquez C V. Myosin ii has distinct functions in PNS and CNS myelin sheath formation. J Cell Biol 2008, 182: 1171-1184.
110. Sun F, Park KK, Belin S, Wang D, Lu T, Chen G, et al. Sustained axon regeneration induced by co-deletion of PTEN and SoCS3. Nature 2011, 480: 372-375.
111. Narayanan SP, Flores AI, Wang F, Macklin WB. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci 2009, 29: 6860-6870.
112. Harrington EP, Zhao C, Fancy SPJ, Kaing S, Franklin RJM, Rowitch DH, et al. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann Neurol 2010, 68: 703-716.
113. Tyler W, Gangoli N, Gokina P, Kim H, Covey M, Levison SW, et al. Activation of the mammalian target of rapamycin (mToR) is essential for oligodendrocyte differentiation. J Neurosci 2009, 29: 6367-6378.
114. Rosenberg SS, Chan JR. Modulating myelination: knowing when to say Wnt. Genes Dev 2009, 23: 1487-1493.